SHANGHAI, Nov. 18, 2014 /PRNewswire/ -- BioLink 2015, the BioPh & ICSE BioPharm Innovation and International Technology Transfer Summit, co-organized by CCCMHPIE (China Chamber of Commerce for Import & Export of Medicines & Health Products), UBM Live and Beijing Yizhuang Biomedical Park, will be held on January 22nd and 23rd, 2015 at Beijing Yizhuang Biomedical Park.
Photo - http://photos.prnewswire.com/prnh/20141114/158652
Photo - http://photos.prnewswire.com/prnh/20141114/158653
Photo - http://photos.prnewswire.com/prnh/20141114/158655
Logo - http://photos.prnewswire.com/prnh/20140922/147494
This event will gather 200+ decision makers from biopharmaceutical industrial players within China and globally, from the biologics, life science technologies, biopharmaceuticals, bio equipment, CRO and analytical instruments industries.
Through its series of networking opportunities, including speed name card exchanging, project matchmaking and private meetings, BioLink 2015 will be an unparalleled platform for regulatory updates and analysis, technical presentations, technology transfer project promotions, business connections and partnership development.
BioLink 2015 exemplifies a new era for the biopharmaceutical industry
With an emphasis on industrial focal points, the forum consists of the following parts: Keynote Speech, Parallel Sessions, 1-2-1 meeting, Company Presentations and Exhibition. Nearly 30 well-known experts, scholars, entrepreneurs and government officials from home and abroad will be invited to give presentations. They will share insights and examples on a range of issues, including:
- How biopharma innovation has impacted patients
- The current status of Chinese biotechnical development & policies
- How to integrate with the international biopharmaceutical market
- EU regulations & management of biopharmaceuticals
- How to build strategic and innovative life sciences partnerships between China and Denmark & related policies
- How to engage China vaccine stakeholders for WHO vaccine prequalification and GAVI markets
- How to drive strategic innovative partnering to overcome R&D challenges in China
- How to enhance collaborations between pharma and investors on expanding R&D budgets
BioLink 2015 will be the best platform for International Technology Transfers
With the deepening of economic globalization and adjustment of the industrial structure of medical biology, international technology transfers are becoming more dynamic. The organizers of BioLink 2015 have invited around 20 leading biotechnology companies from Denmark, the UK, Israel and Cuba to join the "International Technology Transfer with Match Making" forum and present their recent biotechnology projects and boarding prospects in cooperation with Chinese companies.
Moreover, there will be ample scope to take part in matchmaking, which are informative on their own and can smooth roadblocks and promote dynamic biotechnology transfers.
The organizer is dedicated to building the summit to be one of the best industrial platforms to stimulate the biopharm industry in China.
See you in January in Beijing!
For more information, please visit: www.bj.biophchina.com/en
SOURCE Shanghai UBM Sinoexpo International Exhibition Co., Ltd